pg-lps injections Search Results


pg lps  (ATCC)
99
ATCC pg lps
Peiodontal pathogens and cancer: Summary of mechanistic evidence.
Pg Lps, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pg-lps+injections/Porphyromonas+gingivalis+(Coykendall+et+al%2E)+Shah+and+Collins/pmc11579836-58-6-11
Average 99 stars, based on 1 article reviews
pg lps - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

93
Selleck Chemicals pglps
Fig. 6. Chronic systemic exposure to <t>PgLPS</t> <t>increases</t> <t>GSK3β</t> activation in both microglia and neurons in 10-month old APPNL-F/NL-F mice. (A) The immunoblots showing the p-GSK3β and GSK3β expression in the cortex of APPNL-F/NL-F mice with or without PgLPS injection. (B) The quantitative analyses of the ratio of p-GSK3β to GSK3β immunoblots in (A). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate significant differences between values (**p < 0.01, student’s t test). (C) The correlation between p-GSK3β relative immunoreactivity and T231 relative immunoreactivity in the cortex of saline and PgLPS- injected APPNL-F/NL-F mice. (D) The correlation between PSD95 relative immunoreactivity and T231 relative immunoreactivity in the cortex of saline and PgLPS- injected APPNL-F/NL-F mice. Each circle represents single individual and each line represents linear approximation (N = 3, each group). The Pearson correlation coefficient (r) was used to analyze the strength of the association between the two variables (0.7 ≤| r | < 1 is a highly linear correlation; The Pearson correlation coefficient. (E) Immunofluorescent CLMS images of p-GSK3β (green) and Iba1 (red, left) or Nissl (red, right) in the cortex of APPNL-F/NL-F mice. Scale bar, 20 μm. (F) Mean relative intensity of p-GSK3β in the microglia (Iba1) images of (E). (G) Mean relative intensity of p-GSK3β in the neuron (Nissl) images of (E). Each column and vertical bar represent the mean ± SEM (n = 4, each group). The asterisks indicate significant differences from the saline group (***p < 0.001, student’s t test).
Pglps, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pg-lps+injections/TWS119/pm34391814-113-14-22
Average 93 stars, based on 1 article reviews
pglps - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Peiodontal pathogens and cancer: Summary of mechanistic evidence.

Journal: Periodontology 2000

Article Title: Periodontal pathogens and cancer development

doi: 10.1111/prd.12590

Figure Lengend Snippet: Peiodontal pathogens and cancer: Summary of mechanistic evidence.

Article Snippet: , PC , Animal model , PG‐LPS (lipopolysaccharide from P. gingivalis ATCC 33277) was prepared in physiological saline and intraperitoneally administered to C57BL/J mice , The upregulated expression levels of Reg3A and G might play a key role in PG‐LPS‐related pancreatic cancer in mouse , Hiraki et al. .

Techniques: In Vitro, Activation Assay, Protein-Protein interactions, Animal Model, Infection, Migration, In Vivo, Phospho-proteomics, Expressing, Membrane, Transplantation Assay, Stable Transfection, Injection, Saline, Bacteria, Binding Assay, Activity Assay, Biomarker Discovery, Transformation Assay

Fig. 6. Chronic systemic exposure to PgLPS increases GSK3β activation in both microglia and neurons in 10-month old APPNL-F/NL-F mice. (A) The immunoblots showing the p-GSK3β and GSK3β expression in the cortex of APPNL-F/NL-F mice with or without PgLPS injection. (B) The quantitative analyses of the ratio of p-GSK3β to GSK3β immunoblots in (A). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate significant differences between values (**p < 0.01, student’s t test). (C) The correlation between p-GSK3β relative immunoreactivity and T231 relative immunoreactivity in the cortex of saline and PgLPS- injected APPNL-F/NL-F mice. (D) The correlation between PSD95 relative immunoreactivity and T231 relative immunoreactivity in the cortex of saline and PgLPS- injected APPNL-F/NL-F mice. Each circle represents single individual and each line represents linear approximation (N = 3, each group). The Pearson correlation coefficient (r) was used to analyze the strength of the association between the two variables (0.7 ≤| r | < 1 is a highly linear correlation; The Pearson correlation coefficient. (E) Immunofluorescent CLMS images of p-GSK3β (green) and Iba1 (red, left) or Nissl (red, right) in the cortex of APPNL-F/NL-F mice. Scale bar, 20 μm. (F) Mean relative intensity of p-GSK3β in the microglia (Iba1) images of (E). (G) Mean relative intensity of p-GSK3β in the neuron (Nissl) images of (E). Each column and vertical bar represent the mean ± SEM (n = 4, each group). The asterisks indicate significant differences from the saline group (***p < 0.001, student’s t test).

Journal: Brain, behavior, and immunity

Article Title: GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein NL-F/NL-F knock-in mice.

doi: 10.1016/j.bbi.2021.08.213

Figure Lengend Snippet: Fig. 6. Chronic systemic exposure to PgLPS increases GSK3β activation in both microglia and neurons in 10-month old APPNL-F/NL-F mice. (A) The immunoblots showing the p-GSK3β and GSK3β expression in the cortex of APPNL-F/NL-F mice with or without PgLPS injection. (B) The quantitative analyses of the ratio of p-GSK3β to GSK3β immunoblots in (A). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate significant differences between values (**p < 0.01, student’s t test). (C) The correlation between p-GSK3β relative immunoreactivity and T231 relative immunoreactivity in the cortex of saline and PgLPS- injected APPNL-F/NL-F mice. (D) The correlation between PSD95 relative immunoreactivity and T231 relative immunoreactivity in the cortex of saline and PgLPS- injected APPNL-F/NL-F mice. Each circle represents single individual and each line represents linear approximation (N = 3, each group). The Pearson correlation coefficient (r) was used to analyze the strength of the association between the two variables (0.7 ≤| r | < 1 is a highly linear correlation; The Pearson correlation coefficient. (E) Immunofluorescent CLMS images of p-GSK3β (green) and Iba1 (red, left) or Nissl (red, right) in the cortex of APPNL-F/NL-F mice. Scale bar, 20 μm. (F) Mean relative intensity of p-GSK3β in the microglia (Iba1) images of (E). (G) Mean relative intensity of p-GSK3β in the neuron (Nissl) images of (E). Each column and vertical bar represent the mean ± SEM (n = 4, each group). The asterisks indicate significant differences from the saline group (***p < 0.001, student’s t test).

Article Snippet: The cultured cells were stimulated with PgLPS (1 μg/ml; InvivoGen) or were stimulated with PgLPS pretreated with TWS119 (GSK3β inhibitor; 5 μM; Selleckchem) for 1 h. The MG6 conditioned medium was harvested 48 h after PgLPS stimulation or PgLPS stimulation pretreated with TNF-α inhibitor (1 μM; sigma) for 1 h.

Techniques: Activation Assay, Western Blot, Expressing, Injection, Saline

Fig. 8. PgLPS-induced TNF-α secreted by microglia contributes to tau hyperphosphorylation in cultured neurons. (A) The immunoblots showing S202, T231, S396 and tau5 expression in neurons after treatment with microglia condition medium, PgLPS-primed microglia condition medium or PgLPS-primed microglia condition medium pretreated with TNF-α inhibitor for 48 h. (B, C, D) The quantitative analyses of the ratio of S202, T231, S396 to tau5 immunoblots in (A). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate a statistically significant difference from the control group (FS202(3, 8) = 234.8, FT231(3, 8) = 702.5, FS396(3, 8) = 1577, ***p < 0.001 versus control group, one-way ANOVA test). The daggers indicate a significant difference from PgLPS-primed microglia condition medium group (yyp < 0.01, yyyp < 0.001 versus P-MCM group, one-way ANOVA test). (E) Immunofluorescent CLMS images of MAP2 (red) and T231S396 (green) in primary neuron after treatment with PgLPS, PgLPS-primed microglia condition medium or PgLPS-primed microglia condition medium pretreated with TNF- α inhibitor for 48 h. (F, G) Mean relative intensity of T231 and S396 in the CLSM images of (E). The asterisks indicate a statistically significant difference from the control group (FT231(3, 12) = 154.8, FS396(3, 12) = 2876, ***p < 0.001 versus control group, one-way ANOVA test). The daggers indicate a significant difference from PgLPS-primed microglia condition medium group (yyp < 0.01, yyyp < 0.001 versus P-MCM group, one-way ANOVA test). (H) The immunoblots showing the expression of p-AKT, AKT, p-GSK3β and GSK3β after treatment with microglia condition medium, PgLPS-primed microglia condition medium or PgLPS-primed microglia condition medium pretreated with TNF-α inhibitor for 48 h. (I, J) The quantitative analyses of the ratio of p-AKT to AKT and p-GSK3β to GSK3β im munoblots in (H). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate a statistically significant difference from the control group (Fp-AKT (3, 8) = 14.53, Fp-GSK3β (3, 8) = 46.49, **p < 0.01, ***p < 0.001 versus MCM group, one-way ANOVA test). The daggers indicate a significant difference from PgLPS-primed microglia condition medium group (yp < 0.05, yyp < 0.01 versus P-MCM, one-way ANOVA test).

Journal: Brain, behavior, and immunity

Article Title: GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein NL-F/NL-F knock-in mice.

doi: 10.1016/j.bbi.2021.08.213

Figure Lengend Snippet: Fig. 8. PgLPS-induced TNF-α secreted by microglia contributes to tau hyperphosphorylation in cultured neurons. (A) The immunoblots showing S202, T231, S396 and tau5 expression in neurons after treatment with microglia condition medium, PgLPS-primed microglia condition medium or PgLPS-primed microglia condition medium pretreated with TNF-α inhibitor for 48 h. (B, C, D) The quantitative analyses of the ratio of S202, T231, S396 to tau5 immunoblots in (A). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate a statistically significant difference from the control group (FS202(3, 8) = 234.8, FT231(3, 8) = 702.5, FS396(3, 8) = 1577, ***p < 0.001 versus control group, one-way ANOVA test). The daggers indicate a significant difference from PgLPS-primed microglia condition medium group (yyp < 0.01, yyyp < 0.001 versus P-MCM group, one-way ANOVA test). (E) Immunofluorescent CLMS images of MAP2 (red) and T231S396 (green) in primary neuron after treatment with PgLPS, PgLPS-primed microglia condition medium or PgLPS-primed microglia condition medium pretreated with TNF- α inhibitor for 48 h. (F, G) Mean relative intensity of T231 and S396 in the CLSM images of (E). The asterisks indicate a statistically significant difference from the control group (FT231(3, 12) = 154.8, FS396(3, 12) = 2876, ***p < 0.001 versus control group, one-way ANOVA test). The daggers indicate a significant difference from PgLPS-primed microglia condition medium group (yyp < 0.01, yyyp < 0.001 versus P-MCM group, one-way ANOVA test). (H) The immunoblots showing the expression of p-AKT, AKT, p-GSK3β and GSK3β after treatment with microglia condition medium, PgLPS-primed microglia condition medium or PgLPS-primed microglia condition medium pretreated with TNF-α inhibitor for 48 h. (I, J) The quantitative analyses of the ratio of p-AKT to AKT and p-GSK3β to GSK3β im munoblots in (H). Each column and bar represent the mean ± SEM (n = 3, each group). The asterisks indicate a statistically significant difference from the control group (Fp-AKT (3, 8) = 14.53, Fp-GSK3β (3, 8) = 46.49, **p < 0.01, ***p < 0.001 versus MCM group, one-way ANOVA test). The daggers indicate a significant difference from PgLPS-primed microglia condition medium group (yp < 0.05, yyp < 0.01 versus P-MCM, one-way ANOVA test).

Article Snippet: The cultured cells were stimulated with PgLPS (1 μg/ml; InvivoGen) or were stimulated with PgLPS pretreated with TWS119 (GSK3β inhibitor; 5 μM; Selleckchem) for 1 h. The MG6 conditioned medium was harvested 48 h after PgLPS stimulation or PgLPS stimulation pretreated with TNF-α inhibitor (1 μM; sigma) for 1 h.

Techniques: Cell Culture, Western Blot, Expressing, Control

Fig. 9. A schematic representation of the critical roles performed by microglia in promoting tau hyperphosphorylation of neurons in an Aβ-rich environment during chronic systemic exposure to PgLPS. In microglia, PgLPS induces TNF-α production though the activation of GSK3β/NFκB signaling. In contrast, the effects of PgLPS on neurons are microglia-dependent. In neurons, the microglia-released TNF-α is involved in tau hyperphosphorylation through the activation of AKT/ GSK3β signaling.

Journal: Brain, behavior, and immunity

Article Title: GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein NL-F/NL-F knock-in mice.

doi: 10.1016/j.bbi.2021.08.213

Figure Lengend Snippet: Fig. 9. A schematic representation of the critical roles performed by microglia in promoting tau hyperphosphorylation of neurons in an Aβ-rich environment during chronic systemic exposure to PgLPS. In microglia, PgLPS induces TNF-α production though the activation of GSK3β/NFκB signaling. In contrast, the effects of PgLPS on neurons are microglia-dependent. In neurons, the microglia-released TNF-α is involved in tau hyperphosphorylation through the activation of AKT/ GSK3β signaling.

Article Snippet: The cultured cells were stimulated with PgLPS (1 μg/ml; InvivoGen) or were stimulated with PgLPS pretreated with TWS119 (GSK3β inhibitor; 5 μM; Selleckchem) for 1 h. The MG6 conditioned medium was harvested 48 h after PgLPS stimulation or PgLPS stimulation pretreated with TNF-α inhibitor (1 μM; sigma) for 1 h.

Techniques: Activation Assay